期刊文献+

玻璃体腔注射Avastin治疗糖尿病性黄斑水肿的护理 被引量:2

NURSING CARE FOR VITREOUS CAVITY INJECTION OF AVASTIN TREATING DIABETIC EDEMA OF YELLOW SPOT
下载PDF
导出
摘要 目的探讨糖尿病性黄斑水肿患者采用Avastin玻璃体腔内注射的护理方法。方法总结18例糖尿病性黄斑水肿患者玻璃体腔内注射Avastin的护理方法。护理重点为术前的准备,术后眼压的观察和眼内炎的预防。结果 18例患者治疗12 w后16只眼视力稳定或提高(占88.9%);2只眼视力下降(占11.1%)。治疗12 w后黄斑水肿改善患者有13只眼;18例患者均未出现眼内或全身不良反应。其中1例病人出现一过性眼压升高,经过积极的治疗及护理配合眼压降至正常的范围。结论玻璃体腔内注射Avastin配合针对性的护理措施能巩固治疗糖尿病性黄斑水肿疗效,减少并发症的发生。
出处 《现代医院》 2010年第11期89-90,共2页 Modern Hospitals
  • 相关文献

参考文献11

  • 1WILKINSON C P,FERRIS F L,KIEIN R E,et al.Proposed international clinical diabetic retinoDathv and diabetic macular edema disease severity scales[J].Ophthalmology,2003,110:1677-1682.
  • 2EARLY TREATMENT DIABETIC RETINOPATHY STUDY RESEARCH GROUP.Photocoagulation for diabetic macular edema.Early Treatment Diabetic Retinopathy Study report number 1[J].Arch OphthaImol,1985,103:1796-1806.
  • 3MARTIDIS A,DUKER J S.GREENBERG P B,et al.Intravitreal triamcinolone for refractorv diabetic macular edema[J].Ophthalm0109y,2002,109:920-927.
  • 4JONAS J B,KREISSIG L,SOFKER A,et al.Intravitreal injection of triamcinolone for diffuse diabetic macular edema[J].Arch ophthaImoI,2003,121:57-61.
  • 5TOLENTINO M J,MILLER J W,GRAGOUDAS E S,et al.Intravifreal injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate[J].Ophthalmology,1996,6:1820-1828.
  • 6胡洁,唐仕波,梁小玲,胡忆群,文峰,邵娟,刘清云.玻璃体腔单次注射抗血管内皮生长因子单克隆抗体Bevacizumab治疗糖尿病性黄斑水肿[J].中华眼底病杂志,2008,24(3):172-175. 被引量:9
  • 7唐仕波,胡忆群.年龄相关性黄斑变性脉络膜新生血管的治疗策略[J].眼科,2007,16(4):223-225. 被引量:4
  • 8岑洪译.抗肿瘤新药:首个VEGF抑制剂Bevacizumab上市[J].广西医学,2005,27(4):608-611. 被引量:10
  • 9MOSHFEGHI A A.ROSENFELD P J.PULIAFITO C A.et al.Systemic avastin(avastin)therapy for neovascular age-related macular degeneration:24-week results of an uncontrolled.open label clinical study[J].Ophthalmology,2006,113(11):1-12.
  • 10ROSENFELD P J,MOSHFEGHI A A,PULIAFITO C A.optical coherence tomography findings after an Intravitreal injection of avastin(avastin)for neovascular age-related macular degeneration[J].Ophthal Surg Laser lmag,2005,36(4):331-335.

二级参考文献22

  • 1邹海东,张晳,许迅,汪枫桦,张世杰.上海市静安区曹家渡街道年龄相关性黄斑变性的患病率调查[J].中华眼科杂志,2005,4(1):15-19. 被引量:107
  • 2Wilkinson CP, Ferris FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology, 2003, 110 : 1677- 1682.
  • 3Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol, 1985,103 : 1796-806.
  • 4Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology, 2002, 109: 920-927.
  • 5Jonas JB, Kreissig I, Sofker A, et al. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol, 2003, 121: 57-61.
  • 6Tolentino MJ, Miller JW, Gragoudas ES, et al. Intravifreal injections of vascular endothelial growth factor produce retinal isehemia and mieroangiopathy in an adult primate. Ophthalmology, 1996, 106:1820-1828.
  • 7Avery RL, Pieramici DJ, Rabena MD, et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology, 2006,113 : 363-372.
  • 8Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion : a short-term study. Retina, 2006,26 : 279- 284.
  • 9Arevalo F J, Fromow-Guerra J, Quiroz-Mercado H, et al. Primary intravitreal Bevacizumab (Avastin) for diabetic macular edema- results from the Pan-American Collaborative Retina Study Group at 6-Month Follow-up. Ophthalmology, 2007, 114:743-750.
  • 10Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev, 2004,25 : 581-611.

共引文献20

同被引文献8

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部